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Biotech trees are some of the most heavily regulated
plants in the world, yet no forest management system
certifies the use of them as sustainable. The Responsible
Use: Biotech Tree Principles are the first, and only, set
of practices designed specifically for the long-term stew-
ardship of biotech trees. These Principles may serve as a
framework that certification systems can use when con-
sidering whether biotech trees meet their certification
standards.
Responsible use principles were developed to guide
the long-term stewardship of biotech trees. As forest
biotechnology has taken root and genetically modified
trees are being field-tested for biofuels, species restora-
tion, and disease resistance, the need for a set of global
guiding principles for responsible use of these trees
became apparent. Since this need was not being met by
the international forestry certification schemes, the Insti-
tute of Forest Biotechnology (IFB) developed the
Responsible Use: Biotech Tree Principles in a transpar-
ent, stakeholder driven process over nearly three years.
A broad set of stakeholders have set aside the issues of
whether biotech trees should be used and created these
stewardship principles. The Principles are in recognition
that responsibly used biotech trees have the potential to
benefit society, economies, and the environment in ways
that other trees cannot. Central to these Principles are
core beliefs that:
￿ Biotech trees should benefit people, the environ-
ment, or both
￿ Risks and benefits of biotech trees must be assessed
￿ Transparency is vital and stakeholders must be
engaged
￿ Social equity and indigenous rights are important
and must be respected
￿ Biotech tree use must follow regulations of the
appropriate country
Regulations for biotech trees are stringent in most
parts of the world. From product inception in the lab,
to seedlings grown by tree farmers, it can take years and
cost millions of dollars – and the biotech tree may
never get deregulated. Long growth cycles make gather-
ing scientific information necessary for deregulation dif-
ficult in many countries. However, regulations vary
widely in practice from one country to another. We will
discuss the regulatory frameworks of biotech trees in
Brazil, Chile, U.S., Canada, South Africa, China, and
New Zealand.
Certification systems have yet to address biotech tree
use in a holistic, scientific manner. We will discuss how
the top certification systems in Brazil, Chile, U.S.,
Canada, South Africa, China, and New Zealand address
biotech trees. Along with the regulatory review of these
countries, a framework will be developed that shows
where regulations and certification systems overlap,
diverge, or have significant gaps. This framework will be
a tool to begin a dialogue with certification systems on
how to best bridge these gaps using the Responsible
Use: Biotech Tree Principles.
People have highly disparate opinions about using bio-
tech trees. The reality is that biotech trees are already in
u s et o d a y ,a n dt h e yw i l lb ep u tt ou s ee v e nm o r ei nt h e
future. It is important that we engage society, assess
environmental risks and benefits, and follow best prac-
tices for the stewardship of biotech trees and their pro-
ducts. The IFB, through the Responsible Use Initiative,
will work with relevant forest certification systems to
provide science-based, stakeholder driven assessments Correspondence: adam.costanza@forestbiotech.org
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tainable forestry mechanisms.
The IFB is the only organization to address the sus-
tainability of forest biotechnology on a global scale. The
IFB has been in operation for 10 years as a non-profit
organization. In December 2010 the IFB published the
Responsible Use: Biotech Tree Principles. The Principles
along with a comprehensive Biotech Tree Primer are
available at http://www.responsibleuse.org. Learn more
at IFB’s main website, http://www.forestbiotech.org.
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